$Vroom, Inc.(VRM)$During trading today, shares of VRM stock have shot up by over 35% at midday which is quite substantial. This is also a major bullish turnaround from its past month performance which is down by around 32%. And, in the past six months, shares of VRM stock have fallen by around 90%. While many penny stocks climb with little to no news, VRM made an exciting announcement that is causing its sizable uptick right now.At EOD on May 9th, the company reported its Q1 2022 financials, which exceeded guidance on all key metrics. In addition, it announced a business realignment plan. Looking at the report, we see that its e-commerce units sold increased 26% YoY, with its e-commerce revenue increasing by over 60% YoY. And, the company managed t

$Clover Health Corp(CLOV)$Signals & ForecastThe Clover Health Investments stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.65 and $2.41. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 21, 2022, and

$HIVE Blockchain Technologies Ltd.(HIVE)$reverse stock splits are an admission of a struggling firm — a huge red flag, “Investors are well served to sell their holdings of firms announcing reverse stock splits. Investors not holding securities of those firms should refrain from buying them.”Just as with a stock split, there’s no change to the market capitalization of a company, nor is there a change to each investor’s stake. However, they can still be a sign of trouble. Companies may go through reverse stock splits to avoid being delisted from a stock exchange if they’re nearing the minimum share price allowed on that exchange. They also might do a reverse stock split to improve the company’s public image or draw attention from high-profile i

$Catalyst Biosciences(CBIO)$ Buy Candidate Catalyst Biosciences, Inc. (CBIO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. Therefore, the Zacks rating upgrade for Catalyst Biosciences, Inc. basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price. The change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to

$Clover Health Corp(CLOV)$Clover Health Investments grew its revenue by 188% over the last year. That's a strong result which is better than most other loss making companies. Meanwhile, the share price slid 70%. This could mean hype has come out of the stock because the bottom line is concerning investors. We'd definitely consider it a positive if the company is trending towards profitability. If you can see that happening, then perhaps consider adding this stock to your watchlist.Credit: Nasdaq

$Tiger Brokers(TIGR)$Tiger Brokers Australia’s Chief Strategy Officer Michael McCarthy says the Australian market has “fared better than most” as share markets globally continue to fall.“In Europe and the US, we’ve seen weekly drops for every one of the last five weeks,” he told Sky News host Ross Greenwood.“So while we’ve dropped eight per cent in just four sessions, we’re still a lot better off than many investors around the globe.”

$Vroom, Inc.(VRM)$Vroom (VRM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.

$Credit Suisse Group AG(CS)$ It's gonna be safe. Matter of time it will hit the moon. Credit Suisse tapped an emergency lifeline worth 50 billion Swiss franc ($54 billion) from its central bank on Thursday. The Swiss rescue calmed markets and emboldened the ECB to raise interest rates by another half-a-percentage point on Thursday, confounding traders' bets and sticking to its inflation-fighting efforts.

$Lufax(LU)$ Strong Buy Candidate The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 72.72% during the next 3 months and, with a 90% probability hold a price between $4.36 and $5.84 at the end of this 3-month period. Should take note that LU currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market. Credit: StockInvest

$HIVE Blockchain Technologies Ltd.(HIVE)$KEY TAKEAWAYSA reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares.A reverse stock split does not directly impact a company's value (only its stock price).It can signal a company in distress since it raises the value of otherwise low-priced shares.Remaining relevant and avoiding being delisted are the most common reasons for corporations to pursue this strategy.